Veru Inc. (VERU) Social Stream



Veru Inc. (VERU): $1.04

0.06 (+6.57%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add VERU to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals

Industry

D

Ranked

#159 of 167

in industry

VERU INC (VERU) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering VERU.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-02-01 5 $29 $21 $24.4 $1.04 2246.15%
2022-02-18 5 $29 $21 $24.2 $1.04 2226.92%
2022-04-26 4 $36 $24 $29.2 $1.04 2707.69%
2022-05-13 5 $55 $24 $33.6 $1.04 3130.77%
2022-08-12 5 $55 $24 $34 $1.04 3169.23%
2022-09-23 5 $55 $24 $35.2 $1.04 3284.62%
2022-11-07 4 $55 $24 $36.25 $1.04 3385.58%
2022-11-10 4 $36 $10 $24.25 $1.04 2231.73%
2022-12-07 4 $22 $3 $15.75 $1.04 1414.42%
2023-02-10 4 $22 $2 $14.5 $1.04 1294.23%
2023-02-14 4 $15 $2 $11.25 $1.04 981.73%
2023-03-15 4 $15 $2 $10 $1.04 861.54%
2023-05-08 4 $15 $2 $8 $1.04 669.23%
2023-05-12 4 $9 $2 $5.5 $1.04 428.85%
2023-05-15 4 $9 $2 $4.5 $1.04 332.69%

The Trend in the Analyst Price Target


Over the past 20 months, VERU's average price target has gone down $19.9.

Over the past 49 weeks, VERU's average upside potential has been 288.21%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-06-07 5 55 24 34.00 15.85 114.51%
2022-09-23 4 55 24 36.25 10.22 254.7%
2022-09-23 5 55 24 35.20 10.22 244.42%
2023-04-26 4 15 2 8.00 1.28 525%
2023-05-12 4 9 2 5.50 1.14 382.46%

VERU Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.75 3 0 0 0 0 4

The Trend in the Broker Recommendations


Over the past 151 days, VERU's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for VERU as an investment opportunity.

  • VERU has a greater upside potential (average analyst target price relative to current price) than 1655.05% of all US stocks.
  • In the context of all US stocks, VERU INC's variance in analysts' estimates is lower than -1246.13% of them.
  • VERU INC's number of analysts covering the stock is higher than 380.87% of Healthcare stocks.
  • VERU INC's average analyst price target is higher than 856.53% of stocks in the small market cap category.

Stocks similar to VERU INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IMGN, LFVN, and GOVX.

Is VERU a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7271 seconds.